Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	233.59M
Revenue (ttm)	336.87M
Net Income (ttm)	6.38M
Shares Out	81.39M
EPS (ttm)	0.08
PE Ratio	36.34
Forward PE	15.94
Dividend	0.05 (1.71%)
Ex-Dividend Date	May 15, 2025

Volume	5,972
Average Volume	25,219
Open	2.900
Previous Close	2.910
Day's Range	2.850 - 2.910
52-Week Range	2.460 - 3.400
Beta	0.74
RSI	47.33
Earnings Date	Nov 5, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,437
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.